Navigation Links
InterMune to Present at J.P. Morgan Healthcare Conference
Date:1/6/2009

BRISBANE, Calif., Jan. 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Daniel G. Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2009 at 1:00 p.m. PST.

To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Call/--Sigma-AldrichCorporation(Nasdaq: SIAL )will...mber1stat1:45PMGMTinLondon,7:45AMUS/CST.Interested...etavailableat http://inve s tor.sig m a a l...thisfile. ,, AboutSigma-Aldrich: Sigma-Aldri...schemicalandbiochemicalproductsandkitsareusedinsci...
(Date:11/24/2009)...ewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: D..."motionsbytheU.S.BankruptcyCourtfortheDistrictofDe...voluntarypetitionfor,reliefunderChapter11oftheUnit..., TheordersissuedbytheBankruptcyCourtallowthecom...r11proceedings.Inparticular,the,companyreceivedint...
(Date:11/24/2009)...e-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abioph...lizingnovelpainmanagementtherapies,announcedtodayt...r,isscheduledtopresentatthe21stAnnualPiperJaffrayH...ewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTon...availabletorespondtoquestionsduringthepresentation...
(Date:11/24/2009)...MarbleEnergyCorp.announcedtodaythatthecompanyandth...yawarded$2millionbyWashingtonState,sCommunityEcono...ershiptoconstructthestate,sfirstspecialtybiochemic...mentwillsignificantlyspeedthedevelopmentofourbiore...BlueMarbleEnergyCEOKellyOgilvie."Wearegratefultoth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
... July 10 Today,s Pharmaceutical Research,and Manu...end the practice,of providing non-educational mate...ng the value of the physician/industry representat...Institute, a leading non-profit,organization dedic...tatives., (Logo: http://www.newscom.com/cgi-bin/...
... of Four Clinical Stage Product Candidates Adds to... DALLAS, July 10 Access Pharmaceuticals, Inc.,(OT...(OTC Bulletin Board:,MACM) announced today that th...ing for Access to acquire MacroChem through the is...cals, common stock. MacroChem,s product,portfolio ...
...na, July 10 /Xinhua-PRNewswire/ -- WuXi PharmaTech...gy and medical device research,and development out...United,States, today announced that it has appoint..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...Tech, Dr. Yu worked at Pfizer Inc., where,she co-l...
Other Biology Technology:CMR Institute: Education Key to Physician/Representative Relationship 2Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp. 2Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp. 3Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp. 4WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy 2
(Date:11/25/2009)... the Cell Death Research Laboratory in the Univers...rded the prestigious Johnson & Johnson Focused Fun... brain cell damage in Parkinson,s disease. The awa...pport of innovation and excellence in science, was...er this month at an event at the Hyatt Regency Hot...
(Date:11/24/2009)...s been prescribed by traditional healers in Brazil...tomach pain to fever and flu. , Now for the first...en able to scientifically prove the pain relieving...s Brazilian mint. , Testing this ancient South Am...aciela Rocha was able to show that when prepared a...
(Date:11/24/2009)... remarkable class of ring-shaped protein motors ha...Berkeley National Laboratory (Berkeley Lab) using ...e at the Advanced Light Source (ALS). These protei... replication, and are vital to the survival of all...uch as the human papillomavirus, which has been li...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Insurance Leader Praises Senator Kennedy for Promoting Long Term Care Aid for All Americans as Part of Health Reform 48252 1Insurance Leader Praises Senator Kennedy for Promoting Long Term Care Aid for All Americans as Part of Health Reform 48252 2Insurance Leader Praises Senator Kennedy for Promoting Long Term Care Aid for All Americans as Part of Health Reform 48252 3Insurance Leader Praises Senator Kennedy for Promoting Long Term Care Aid for All Americans as Part of Health Reform 48252 4MEDomics Announces MitoDx 28TM 29 the First NextGen Mitochondrial Genome Diagnostic Test 12533 1MEDomics Announces MitoDx 28TM 29 the First NextGen Mitochondrial Genome Diagnostic Test 12533 2MEDomics Announces MitoDx 28TM 29 the First NextGen Mitochondrial Genome Diagnostic Test 12533 3ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe 48251 1ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe 48251 2
...ng Sun Lee and Anindya Dutta (UVA) reveal that mic... , "Overexpression of HMGA2 is an important featu... fibroids,?explains Dr. Dutta. “It is very excitin... in suppressing the overexpression of HMGA2, and s... cure of a disease that is responsible for the vas...
...ntial mates with showy traits, many of which are l... suggests that, in fish, choosing a flashier mate ...e to pathogens. , In the January 2007 issue of The...(Uppsala University, Sweden) finds that mating wit...olors or long tails and fins ?results in higher te...
... stage at which some of the cells of a fertilised ... and why this occurs. The findings of the study, ... the same until the fourth cleavage (division) of ...ure. , After fertilisation, the cells of the embr...nd unequal, asymmetrical ones that direct smaller ...
Other Biology News:Scientists discover stage at which an embryonic cell is fated to become a stem cell 2
Standard and Modified Oligonucleotides Service from Yorkshire Bioscience Ltd
...20 years of expertise in the field of Enzyme-Linke...he most powerful systems on the market. Freedom EV...requiring incubation and washing steps. The inte...aker incubators, reader,washer), all controlled by...
...d Choice Microsphere/Microarray Stabilizer is a is...lus Stabilizer. This product is an aqueous soluti...er (phosphate buffered saline), pH 6.6 - 7.2. Thi...othiazolone and 0.02% bromonitrodioxane as a prese...
Rabbit Anti-JKK / SEK1 / MKK4, phospho Antibody, Unconjugated from MBL International
Biology Products: